2024 France Molecular Diagnostic Analyzers and Reagent Market Shares and Forecasts for 100 Tests: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

2024 France Molecular Diagnostic Analyzers and Reagent Market Shares and Forecasts for 100 Tests: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • May 2020 •
  • 1125 pages •
  • Report ID: 5902333 •
  • Format: PDF
2024 France Molecular Diagnostic Analyzers and Reagent Market Shares and Forecasts for 100 Tests: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new 1,125-page report contains 58 tables.

The report is available by section, and can be customized to specific information needs and budget. The report presents comprehensive analysis of the French molecular diagnostics market, including:

  • Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:
   -  Infectious Diseases

   -  Genetic Diseases

   -  Cancer

   -  Paternity Testing/HLA Typing

   -  Forensic Testing

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 1,125 pages and 58 tables



Companies Profiled

Competitive Assessments

- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- LabCorp
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher